SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

76 hedge funds and large institutions have $246M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
–
Holders Change %
0%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
25
Reduced
25
Closed
8
Calls
$464K
Puts
$279K
Net Calls
+$185K
Net Calls Change
+$308K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$5.03M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.92M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.79M
4
WCM
Wedge Capital Management
North Carolina
+$731K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$519K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$2.41M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.63M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.59M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.01M
5
Two Sigma Investments
Two Sigma Investments
New York
-$715K
Name Holding Trade Value Shares
Change 		Shares
Change %
KF
76
Krilogy Financial
Missouri
$1K +$1K +10 New
MWNA
77
Marshall Wace North America
New York
– -$373K -3,651 Closed
QSS
78
Quantitative Systematic Strategies
Florida
– -$303K -2,967 Closed
Citadel Advisors
79
Citadel Advisors
Florida
– -$186K -1,821 Closed
DTL
80
Dynamic Technology Lab
Singapore
– -$177K -1,730 Closed
Prudential Financial
81
Prudential Financial
New Jersey
– -$156K -1,530 Closed
ARTA
82
A.R.T. Advisors
New York
– -$112K -1,100 Closed
PCM
83
Prelude Capital Management
New York
– -$8K -75 Closed
PIA
84
Piedmont Investment Advisors
North Carolina
– -$4K -43 Closed
1 2 3
4